500
Views
6
CrossRef citations to date
0
Altmetric
Author's View

Identification of new prognostic biomarkers for Stage III metastatic melanoma patients

, , &
Article: e25564 | Received 25 Jun 2013, Accepted 27 Jun 2013, Published online: 03 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Lorenzo Galluzzi, Alexander Eggermont & Guido Kroemer. (2016) Doubling the blockade for melanoma immunotherapy. OncoImmunology 5:1.
Read now
Aitziber Buqué, Norma Bloy, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Aurélien Marabelle, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. OncoImmunology 4:4.
Read now
Lorenzo Galluzzi, Guido Kroemer & Alexander Eggermont. (2014) Novel immune checkpoint blocker approved for the treatment of advanced melanoma. OncoImmunology 3:11.
Read now

Articles from other publishers (3)

Alyson L. Mahar, Carolyn Compton, Susan Halabi, Kenneth R. Hess, Jeffrey E. Gershenwald, Richard A. Scolyer & Patti A. Groome. (2016) Critical Assessment of Clinical Prognostic Tools in Melanoma. Annals of Surgical Oncology 23:9, pages 2753-2761.
Crossref
Tulay Akman, Ilhan Oztop, Yasemin Baskin, Mahdi Akbarpour, Olcun Umit Unal, Utku Oflazoglu & Hulya Ellidokuz. (2014) The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy. Medical Oncology 32:1.
Crossref
Ling Zhou, Yuangang Lu, Guihong Yang & Jinjin Wu. (2014) Research on tumorigenicity of cinnamaldehyde in melanoma cell lines and its mechanism. Tumor Biology 35:6, pages 5717-5722.
Crossref